Companion apps are designed to support patient onboarding, engagement and adherence around a specific treatment. These digital solutions are highly user-centric, offering personalized support and resources to help patients better navigate their treatment journey.
Common key features includeÂ
Physical activity and nutrition programs additional modules tailored to each specific use cas

Patient safety and data protection are core to our development approach. We combine UX design, medical, engineering and quality & regulatory expertise to deliver solutions that meets high standards of reliability, security and compliance.
Our teams operate within regulated quality systems and secure hosting environments to support the responsible deployment of digital health solutions.
sdsas

A disease management platform provides a proactive and comprehensive approach that aims to improve the quality of life of patients with chronic diseases, while seeking to reduce healthcare costs.
It involves coordinated interventions and communications between different stakeholders for chronic diseases where self-management efforts can play an important role. By leveraging a comprehensive digital platform, patients can easily track the progress of their disease, communicate better with their healthcare team and live an enhanced treatment experience.
SaMD offers pharmaceutical companies an opportunity toextend the value of their therapies through regulated digital asset. . By developing a SaMD solution, we help patients managing their medication more effectively and enhancingthe treatment adherence. Building and validating clinical evidence through rigorous trials and studies ensures the safety and efficacy of these solutions.
When integratedwith drug assets, SaMD contributes to a more personalized and comprehensive treatment experience, ultimately improving outcomes and patient satisfaction.
Our technology platform integrates with established solutions/PSPs to optimize patient experience through complementary digital modules. By leveraging pre-developed modules, our PSP solutions help reduce development timelines while addressing patients’ evolving needs, including engagement, education, and adherence support.
SureStartRx® is a tailored digital program designed to support patients initiating self-injected therapies. Developed with our sister company Noble, an Aptar Pharma company, the program combines a training device with digital education from the first dose.
SureStartRx® helps bridge the gap between dispensing medication and long-term adherence by supporting patients early in their treatment journey.